Pioglitazonehydrochloride
Product Images NDC 53002-1755

6 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pioglitazonehydrochloride (NDC 53002-1755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021755)

Label Image (Lbl530021755)
Label for PIOGLITAZONE HCL 15MG TABLETS by RPK Pharmaceuticals, Inc. The label specifies 30 tablets per bottle with instructions to take one tablet daily or as directed. It includes patient name, lot number, fill date, and barcode, along with reminders to monitor blood sugar and read the patient information carefully before use.*
FDA Label Image

Label Image (Lbl530021757)

Label Image (Lbl530021757)
Label for Pioglitazone Hydrochloride 45 mg tablets by RPK Pharmaceuticals, Inc. The label indicates a package containing 30 tablets. Directions state to take one tablet daily or as directed. Additional labeling includes lot number, expiration date, billing NDC numbers, and space for patient and clinic information.*
FDA Label Image

Structure (Pioglitazonetablets Figure 01)

Structure (Pioglitazonetablets Figure 01)
Chemical structure of Pioglitazone Hydrochloride, showing its molecular arrangement including aromatic rings and functional groups characteristic of this active ingredient.*
FDA Label Image

Figure (Pioglitazonetablets Figure 02)

Figure (Pioglitazonetablets Figure 02)
A line graph comparing the mean response over 26 weeks for different dosages of Pioglitazone Hydrochloride and a placebo. The x-axis represents weeks, and the y-axis represents mean values. Four lines represent placebo, 15 mg, 30 mg, and 45 mg dosages, showing trends over time.*
FDA Label Image

Logo (Pioglitazonetablets Figure 03)

FDA Label Image

Logo (Pioglitazonetablets Figure 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.